Source: Marketing Authorisation Holder Revision Year: 2015
Duovent UDV (ipratropium bromide/fenoterol hydrobromide).
| Route of Administration | Dosage Form/Strength | Nonmedicinal Ingredients |
| Inhalation | Solution/0.5 mg of ipratropium bromide and 1.25 mg fenoterol hydrobromide in 4 mL of isotonic saline | sodium chloride, hydrochloric acid |
DUOVENT nebulizer solution is provided as plastic single unit dose vials (UDV) filled with 4 mL of clear, colourless, isotonic aqueous solution containing 0.5 mg of ipratropium bromide and 1.25 mg fenoterol hydrobromide.
Each millilitre of the solution contains 0.125 mg of ipratropium bromide and 0.3125 mg of fenoterol hydrobromide. Non-medicinal ingredients include sodium chloride and hydrochloric acid to adjust the pH.
Each carton contains 2 strips of 10 × 4 mL UDVs. Each UDV strip is packaged in an aluminum/Low Density Polyethylene (LDPE) pouch.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
Boehringer Ingelheim (Canada) Ltd., 5180 South Service Road, Burlington, Ontario, L7L 5H4
180942
|
Date of revision:
March 30, 2015 |
| Drug | Countries | |
|---|---|---|
| DUOVENT | Brazil, Singapore, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
